Keywords: vioxx, follow-up, does, well, vs, ibuprofen, merck

Vioxx follow-up does well vs ibuprofen

Article | 31 May 2001

Print This

Merck & Co's second-generation COX-2 inhibitor etoricoxib, a follow upto its Vioxx (rofecoxib) product, has been shown in a new study ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in